Anuh Pharma logo

Anuh Pharma financials: balance sheet, profit and loss, cash flow

NSE: ANUHPHRBSE: 506260Pharmaceuticals & BiotechnologySmall Cap

Anuh Pharma Limited · Face value ₹5 · Listed Jan 1961 on BSE, Dec 2024 on NSE
Last close ₹79.74up ₹0.13 (0.16%)BSE ₹80.00

Share price at the NSE close on 29 Oct 2026. Previous close ₹79.61.

29 Oct: open ₹81.50, high ₹81.50, low ₹79.00

52-week range of traded prices to 29 Oct 2026
₹67.00Low, 30 Mar 2026₹99.50High, 8 Sep 2026
Market cap
₹799 Cr1,625th largest listed
P/E
18.09
P/B
2.27
Dividend yield
1.88%
ROE
13.0%
ROCE
15.2%
Debt to equity
0.00
Volume, NSE
48,01053.5% delivered

Anuh Pharma's financial statements for the 10 years to Mar 2026, standalone: the listed company alone, without its subsidiaries, with the twelve months to Jun 2026 after them. It had no borrowings at 31 Mar 2026.

10 years at a glance

₹ crore, years to March.Anuh Pharma annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
20618Mar 1724117Mar 18321234.4Mar 193071445Mar 204322814Mar 21487313.1Mar 22527360Mar 23647602.0Mar 246624710Mar 25772410Mar 26
Peak revenue ₹772 Cr, year to Mar 2026; lowest ₹206 Cr, year to Mar 2017

Operating and net margin, per cent

  • Operating margin
  • Net margin
11.6%4.7%10.9%7.4%9.2%7.4%10.3%9.6%9.7%11.6%9.2%8.0%8.5%6.8%7.3%4.7%6.6%6.3%6.9%9.3%7.2%5.3%Mar 17Mar 19Mar 21Mar 23Mar 25Mar 26

From Apr 2019 leases sit on the balance sheet: rent is charged as depreciation and interest instead, so operating profit and total assets step up with nothing about the business having changed. Borrowings here leave lease liabilities out. Lease payments were 1.2% of operating profit in the first full year.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue772
  2. Materials and goods−600
  3. Employee costs−26
  4. Other expenses−84
  5. Operating profit62
  6. Depreciation−11
  7. Other income+4.4
  8. One-off items0.0
  9. Finance costs−0.5
  10. Profit before tax54
  11. Tax−13
  12. Net profit41

What the company owns

  • Receivables₹239 Cr
  • Inventory₹148 Cr
  • Plant, investments and other assets₹118 Cr
  • Current investments₹45 Cr
  • Cash and bank₹8 Cr

What pays for it: net worth and liabilities

  • Net worth₹352 Cr
  • Owed to suppliers₹188 Cr
  • Other liabilities₹17 Cr

Profit and loss

Standalone, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Anuh Pharma quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 24 MayMar 2026Filed 20 MayJun 2026Twelve monthsFiled 7 Aug
Revenue from operations206241321307432487527647662772779
184223291284387440476572601710714
Materials and goods bought151181243230330378401487499600595
Employee costs7–101314151719232627
Other expenses26–384143475866788491
Operating profit before depreciation2318302345475175616265
Operating margin10.9%7.4%9.2%7.4%10.3%9.6%9.7%11.6%9.2%8.0%8.3%
Materials, % of revenue73.1%–75.8%75.0%76.3%77.6%76.1%75.2%75.5%77.7%76.4%
Employee costs, % of revenue3.5%–3.2%4.4%3.3%3.1%3.3%3.0%3.5%3.4%3.5%
Other expenses, % of revenue12.5%–11.9%13.2%10.0%9.7%10.9%10.2%11.8%10.9%11.7%
Depreciation and amortisation2227151210991111
Operating profit after depreciation2116281630354267525054
Other income5754115612947
Finance costs00011100100
One-off items––000000000
Profit before tax2523321939394778615460
87951091118141316
Net profit1817231428313660474144
Other comprehensive income––000000000
Total comprehensive income––231428313660474144
Net margin8.5%6.8%7.3%4.7%6.6%6.3%6.9%9.3%7.2%5.3%5.7%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank.
Earlier years, Mar 2008 to Mar 2016
₹ croreMar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue from operations111121165176226243266284326
101102154160205223240251287
Materials and goods bought9393144148192203211219249
Operating profit before depreciation91911152119273339
Operating margin8.6%15.7%6.6%8.8%9.3%8.0%10.1%11.6%12.1%
Depreciation and amortisation111112232
Operating profit after depreciation81810142018253037
Other income3−493−10121
Finance costs010000000
Profit before one-off items and tax–1318171818253238
One-off items––––––−8––
Profit before tax111318171818183238
Tax455555–1012
Net profit8913121313182226
Net margin7.0%7.2%7.8%6.9%5.7%5.2%6.6%7.8%7.9%
Standalone, ₹ crore, years to March.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 24 MayMar 2026Filed 20 May
165162191214241291326352
Share capital1313252525252550
Reserves152150166189216266301302
Borrowings44514302100
75163139131161153179203
11322222
Total assets240326333347405446507557
88102958897109130106
152224238259308336376451
Net debt−16−24−18−34−58−63−63−53
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 24 MayMar 2026Filed 20 May
−18.728.953.912.937.1−3.0
−9.038.067.432.048.210.2
−55.2−9.415.2−43.6−13.1−54.9
Receivables−25.8−28.8−35.3−18.7−27.1−19.9
Inventories−19.91.57.3−2.80.9−73.3
Payables15.41.631.2−12.617.724.0
Other working capital−24.816.312.0−9.5−4.614.3
Tax paid−9.7−9.1−13.5−19.1−11.1−13.2
Capital spending6.21.61.64.520.07.9
Free cash flow−24.927.252.48.417.2−10.9
52.2−7.8−43.50.9−19.917.8
−33.1−19.4−12.3−8.6−4.9−26.3
Dividends paid0.07.68.710.012.515.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash0.41.6−1.95.312.4−11.5
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.Anuh Pharma dividend history

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 24 MayMar 2026Filed 20 May
––––₹2.84₹3.05₹3.61₹5.99₹4.73₹4.10
As stated that year₹7.02₹6.59₹9.33₹5.71₹5.68₹6.10₹7.22₹11.98₹9.45₹4.10
––––₹2.84₹3.05₹3.61₹5.99₹4.73₹4.10
Dividend per share––––––––₹1.50₹1.50
––––₹19.02₹21.33₹24.07₹29.06₹32.53₹35.14
Dividend payout––––––––31.7%36.6%
Shareholder yield––––0.0%1.8%2.2%0.8%1.7%2.2%
Market cap at the year end (₹ crore)5043923392924534313991,231748672
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Standalone, years to March.Anuh Pharma PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Filed 24 MayMar 2026Filed 20 May
Revenue growth−36.8%17.0%32.9%−4.3%40.7%12.7%8.4%22.7%2.2%16.7%
Operating profit growth−42.7%−20.5%65.0%−22.9%95.8%5.1%9.5%46.6%−18.9%1.3%
Net profit growth−31.9%−6.1%41.5%−38.8%98.8%7.5%18.4%66.0%−21.2%−13.3%
Earnings per share growth–––––7.5%18.4%65.9%−21.1%−13.2%
––14.2%8.8%16.1%15.1%15.9%22.6%15.3%12.1%
–––−5.4 pts7.4 pts−1.0 pts0.8 pts6.7 pts−7.2 pts−3.2 pts
From the net margin–––−5.1 pts3.6 pts−0.7 pts1.4 pts5.6 pts−5.2 pts−3.9 pts
From asset turnover–––−1.7 pts2.6 pts1.4 pts−0.3 pts1.8 pts−1.5 pts0.5 pts
From borrowing–––1.4 pts1.2 pts−1.7 pts−0.3 pts−0.8 pts−0.5 pts0.2 pts
Return on capital employed––16.5%7.6%14.4%16.1%17.2%22.7%15.5%14.3%
Cash conversion––––−65.9%94.4%149.0%21.5%78.4%−7.3%
Interest cover468.3396.7163.019.919.736.3190.4188.384.2106.6
Debt to equity––0.030.270.070.010.000.010.030.00
Receivable days––859690102118107119113
Inventory days––6498907766575490
Payable days––89166133117139105115114
Cash conversion cycle, days––6128486246585989
Working capital days––7045687061687492
Asset turnover––1.331.081.311.431.401.521.391.45
Assets per rupee of net worth––1.461.731.871.681.651.601.541.57
Sales per rupee of plant––15.403.696.078.0910.1713.4113.3416.08
Capital spending to depreciation––––0.410.140.160.532.280.69
Plant being built, % of plant in use––162.6%0.0%0.0%0.2%0.0%0.9%0.5%0.0%
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
7.7%
Cash from operations against operating profit
−4.9%
Measure10 years5 years3 years
Revenue growth, yearly rate9.0%12.3%13.5%
Profit growth, yearly rate4.8%7.6%4.3%
Return on equity, average–16.2%16.7%
Return on capital employed, average–17.2%17.5%
Operating margin, average9.3%9.6%9.6%
Net margin, average6.9%7.0%7.3%
Asset turnover, average–1.441.45
Cash conversion cycle, days, average–6369
Interest cover, average167.3121.1126.4
Debt to equity, average–0.010.01

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations13047−3
Cash from investing−52−118
Cash from financing−71−40−26
Capital spending36328
Dividends paid543815
Shares bought back000
Shares issued for cash000
Borrowings raised–100
Borrowings repaid101010

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––467733
Altman Z-scorePublished threshold 1.81––5.743.084.664.924.338.155.494.97
Beneish M-scorePublished threshold −1.78––––−1.56−1.73−2.64−1.00−2.19−2.13
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−1.532.806.8510.876.334.93
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.670.750.720.32
Receivables growth less revenue growthOur threshold 0 percentage points–––12.99−8.8514.3417.78−11.7211.40−6.10
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––48.75−10.86−16.36−15.42−17.41−3.8378.30
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−0.701.21−2.580.120.000.93−0.10
Assets under construction, years of additionsOur threshold 2 years of additions–––0.000.000.100.000.090.030.00
Effective tax ratePublished threshold 17.16 per cent30.0029.4927.8925.3226.2421.8823.7823.3122.3824.30
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−1.48−4.58−1.044.15−0.12
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
15 Sep 2025ICRA LimitedInterchangeable-Cash Credit[ICRA]A-Review, Re-affirmPositive5
15 Sep 2025ICRA LimitedNon Fund Based-Letter of Credit[ICRA]A2+Review, Re-affirm90
15 Sep 2025ICRA LimitedInterchangeable-Export Packing Credit[ICRA]A2+Review, Re-affirm60
15 Sep 2025ICRA LimitedInterchangeable-Bank Guarantee[ICRA]A- /[ICRA]A2+Review, Re-affirmPositive90
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.